Inventor · disambiguated record
Reza Dana
Also filed as: DANA REZA
25 granted patents·26 pending applications·86 citations·filing 2005–2025
95Inventor score
Files withSCHEPENS EYE RES INST23MASSACHUSETTS EYE & EAR INFIRMARY12DANA REZA8SERHAN CHARLES N3BRIGHAM & WOMENS HOSPITAL INC2
Top patents by PatentIndex Score
51 records- 0194US11241497B2Therapeutic compositions for treatment of ocular inflammatory disordersSCHEPENS EYE RES INST·Filed 2017·Granted Feb 8, 2022·7 cites·10 claims
- 0293US9328162B2Therapeutic compositions for the treatment of dry eye diseaseDANA REZA·Filed 2011·Granted May 3, 2016·9 cites·22 claims
- 0393US9011861B2Therapeutic compositions for the treatment of dry eye diseaseDANA REZA·Filed 2011·Granted Apr 21, 2015·9 cites·22 claims
- 0490US10179160B2Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2016·Granted Jan 15, 2019·3 cites·16 claims
- 0590US9549966B2Inflammatory eye disordersMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2013·Granted Jan 24, 2017·12 cites·12 claims
- 0690US2025195608A1Therapeutic Compositions for the Treatment of Dry Eye DiseaseSCHEPENS EYE RES INST·Filed 2024·Application pending·0 cites
- 0789US9670277B2Compositions and methods for treating inflammatory conditions of the ocular surfaceDANA REZA·Filed 2012·Granted Jun 6, 2017·5 cites·10 claims
- 0888US11844571B2Grading corneal fluorescein stainingMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2022·Granted Dec 19, 2023·1 cites·20 claims
- 0988US10449234B2Compositions and methods for prevention and treatment of corneal haze and scarringSCHEPENS EYE RES INST·Filed 2016·Granted Oct 22, 2019·3 cites·8 claims
- 1084US10940179B2Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2018·Granted Mar 9, 2021·2 cites·10 claims
- 1184US9309313B2Therapeutic compositions for treatment of ocular inflammatory disordersDANA REZA·Filed 2009·Granted Apr 12, 2016·6 cites·10 claims
- 1284US9278120B2Inflammatory eye disordersMASSACHUSETTS EYE & EAR INFIRM·Filed 2013·Granted Mar 8, 2016·9 cites·8 claims
- 1381US10492674B2Grading corneal fluorescein stainingMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2018·Granted Dec 3, 2019·3 cites·20 claims
- 1481US2024123032A1Compositions and methods for prevention and treatment of corneal haze and scarringSCHEPENS EYE RES INST·Filed 2023·Application pending·0 cites
- 1579US11350820B2Grading corneal fluorescein stainingMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Granted Jun 7, 2022·2 cites·20 claims
- 1679US9872901B2Therapeutic compositions for treatment of ocular inflammatory disordersSCHEPENS EYE RES INST·Filed 2016·Granted Jan 23, 2018·2 cites·20 claims
- 1778US11058800B2Bioadhesive for corneal repairBRIGHAM & WOMENS HOSPITAL INC·Filed 2017·Granted Jul 13, 2021·2 cites·12 claims
- 1878US10548474B2Calculating conjunctival rednessMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2017·Granted Feb 4, 2020·2 cites·20 claims
- 1977US9877645B2Inflammatory eye disordersMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2017·Granted Jan 30, 2018·1 cites·18 claims
- 2077US2022088119A1Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2021·Application pending·0 cites
- 2177US2025161402A1Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2025·Application pending·0 cites
- 2276US2021154263A1Therapeutic compositions for the treatment of dry eye diseaseSCHEPENS EYE RES INST·Filed 2021·Application pending·0 cites
- 2375US11759499B2Compositions and methods for prevention and treatment of corneal haze and scarringSCHEPENS EYE RES INST·Filed 2021·Granted Sep 19, 2023·0 cites·10 claims
- 2475US10117906B2Methods for reducing corneal nerves damage, corneal lymphangiogenesis or immunity to corneal antigens in dry-eye associated ocular surface diseases by IL-1RaDANA REZA·Filed 2010·Granted Nov 6, 2018·5 cites·15 claims
- 2575US2019151404A1Therapeutic compositions for the treatment of dry eye diseeaseSCHEPENS EYE RES INST·Filed 2018·Application pending·0 cites
- 2671US10105441B2Method for inhibiting or reducing dry eye disease by IL-1RaDANA REZA·Filed 2008·Granted Oct 23, 2018·2 cites·12 claims
- 2771US8722654B2Lipoxin analogs as novel inhibitors of angiogenesisSERHAN CHARLES N·Filed 2011·Granted May 13, 2014·1 cites·2 claims
- 2871US2024269347A1Bioadhesive for corneal repairBRIGHAM & WOMENS HOSPITAL INC·Filed 2023·Application pending·0 cites
- 2969US2020121758A1Compositions and methods for prevention and treatment of corneal haze and scarringSCHEPENS EYE RES INST·Filed 2019·Application pending·0 cites
- 3065US2021353829A1Bioadhesive for corneal repairMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2021·Application pending·0 cites
- 3164US2025312412A1Methods for treating dry eye diseaseSCHEPENS EYE RES INST·Filed 2023·Application pending·0 cites
- 3264US2015246966A1Therapeutic Compositions for the Treatment of Dry Eye DiseaseSCHEPENS EYE RES INST·Filed 2015·Application pending·0 cites
- 3362US11298018B2Calculating conjunctival rednessMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2019·Granted Apr 12, 2022·0 cites·22 claims
- 3459US2010105772A1Use of novel lipid mediators to inhibit angiogenesisSERHAN CHARLES N·Filed 2009·Application pending·0 cites
- 3557US2024033219A1Compositions and methods for mucosal drug deliveryUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 3656US2017290888A1Compositions and Methods for Treating Inflammatory Conditions of the Ocular SurfaceTHE SCHEPENS EYE RES INST INC·Filed 2017·Application pending·0 cites
- 3752US2008153909A1Compositions and methods for treating eye disorders and conditionsSCHEPENS EYE RES INST·Filed 2007·Application pending·0 cites
- 3851US9854970B2Calculating conjunctival rednessMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2013·Granted Jan 2, 2018·0 cites·16 claims
- 3950US2022387668A1Cultivated Autologous Limbal Epithelial Cell (CALEC) TransplantationMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2020·Application pending·0 cites
- 4048US10004395B2Grading corneal fluorescein stainingMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2015·Granted Jun 26, 2018·0 cites·22 claims
- 4148US2011301239A1Use of novel lipid mediators to inhibit angiogenesisSERHAN CHARLES N·Filed 2009·Application pending·0 cites
- 4247US2015307619A1Use of C-C Chemokine Receptor Type 7 (CCR7) InhibitorsSCHEPENS EYE RES INST·Filed 2013·Application pending·0 cites
- 4346US11306140B2Therapeutics for ocular immunoinflammatory diseasesSCHEPENS EYE RES INST·Filed 2017·Granted Apr 19, 2022·0 cites·9 claims
- 4446US2006009522A1Compositions and methods for treating eye disorders and conditionsDANA REZA·Filed 2005·Application pending·0 cites
- 4545US2013273065A1Therapeutic Compositions For Treatment Of Inflammation Of Ocular And Adnexal TissuesSCHEPENS EYE RES INST·Filed 2013·Application pending·0 cites
- 4644US2022288028A1A therapeutic approach for treating non-infectious ocular immunoinflammatory disordersSCHEPENS EYE RES INST·Filed 2020·Application pending·0 cites
- 4743US2007265341A1Compositions and methods for treating eye disorders and conditionsSCHEPENS EYE RES INST·Filed 2007·Application pending·0 cites
- 4843US2022001074A1Bioadhesive for Soft Tissue RepairSCHEPENS EYE RES INST·Filed 2019·Application pending·0 cites
- 4941US2020188441A1Methods and compositions for reducing corneal endothelial cell lossSCHEPENS EYE RES INST·Filed 2018·Application pending·0 cites
- 5038US2024050621A1Ocular sealants and methods of using the sameMASSACHUSETTS EYE & EAR INFIRMARY·Filed 2020·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Reza Dana files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →